For those patients with metastatic Ewing’s sarcoma please review the inclusion and exclusion criteria for the Vigil clinical trial below:
http://www.vigilclinicaltrials.com/vigil-immunotherapy-ewings-sarcoma-clinical-trial/
Immunotherapy Clinical Trial for Ewing’s
Join the Sarcoma Strong Community
Every story has the power to inspire, educate, and create change. Join the Sarcoma Strong community to stay connected with the people, experiences, and breakthroughs that are making an impact in the fight against sarcoma.
Related articles
An interview with 2019 SarcomaStrong Grant recipient, Dr. Rosanna Wustrack from UCSF.
Interview with Dr. Rosanna Wustrack by Harjot Uppal, 2nd year medical student at Albany Medical College October 2021 How has the research grant from Sarcoma Strong helped…
SarcomaStrong Highlights from 2021
Raised over $138,000. Surpassed our previous highest fundraising year in 2019 of $105,000 Increased overall participation of our Global event – >1600 participants and donors National and…
Dr. Santiago Lozano-Calderon, 2019 recipient of SarcomaStrong research grant, and his team at Massachusetts General Hospital shed light on the genetics of extraskeletal osteosarcoma.
Sarcoma Strong interview with Dr. Lozano-Calderon by Gokul Kalyanasundaram, 2nd-year medical student at Albany Medical College Learn more about Dr. Lozano-Calderon: https://www.massgeneral.org/doctors/19509/santiago-lozano-calderon How has the grant from…
